Skip to main content

Healthcare - Suggest Solutions?







Health Issues in the Philippines
Like any other third-world country, the Philippines have been struggling in some health issues and one of it is illegal drug use. A lot of Filipinos are addicted to prohibited drugs. However, the Philippine government has dealt with this issue and although there are still some recorded incidents of drug abuse, the number of drug dependents in the Philippines has gradually decreased.
Other concerning health issues in the Philippines, is malnutrition. There have been studies conducted and accordingly, most of the Filipinos that suffer from malnutrition are the poor ones. The Philippine government, thru the Department of Social Welfare and Developments along with the Department of Health has provided projects to help poor Filipinos from starvation.One such big issue is Dengue fever.
Health Care System in Thailand



Thailand has no established primary health care system- Most of the doctors in Thailand are specialists that is why it is hard to find a reliable all around general practitioner to treat you with your minor medical problems. As foreigners, you will have to go to a general hospital, wherein you will be most likely to be examined by a doctor who is specializing in one field to another. Since it is common to have different small medical problems, it is somehow difficult for a medical specialist to deal with that. The best way to do especially if you are not quite so sure about your problem is simply to seek an internist and simply take it from there. Reports have shown that the health care system heavily relies on the specialized medicine. However, there are still some major hospitals in Thailand that have family doctors or medical practitioners. Expatriates can always make use of that.


Big Question?- How to fix India's Healthcare System?



There is a two-way causality between health and economic development. Countries, which are economically well developed, tend to invest more on healthcare.
Greater investment in healthcare also leads to longer life expectancy, less morbidity and increasing work productivity that results in economic progress.
Over the last two decades, life expectancy at birth in India has increased by approximately double the increase in life expectancy in middle income and high-income countries.
However, the average Indian life expectancy is 15 years less than that of a citizen of a high-income country. Notice the low levels of public expenditures on health in India compared to middle income and high-income countries.
The ratio of India's purchasing power parity-adjusted per capita income to that of middle-income countries is 52 per cent and that of high-income countries is 10.6 per cent. The ratio of India's purchasing power parity-adjusted health expenditure per capita is 35 per cent of middle-income countries and 3.6 per cent of rich countries.
Even allowing for some wasteful expenditure in developed countries, we are certainly under investing in health. Notice the low levels of public expenditures on health in India compared to middle income and high-income countries.
The number of physicians per 1000 people has remained unchanged in India over the last twenty years. Another unique feature in the country is the usage of public health services by the bottom 20 per cent of the population (classified by income), which is only marginally higher than the top 20 per cent of the population.
Hence, there is urgent need to rejuvenate the public healthcare system to ensure that the poor get access to essential medical services.
Though the budget resources are scarce, there is certainly a need to double the public expenditure on health, given the long-term benefits. The emphasis should be on prevention and making essential public health services available to the poor.
About 88 per cent of the pregnant women are anaemic. India is unfortunately leading the world in this risk factor. The surprising issue is that this is not related to income distribution.
Other aspects such as low birth weight babies and child malnutrition are close to the poverty line numbers. While deadly diseases such as Tuberculosis and HIV are receiving public attention, the long-term consequences of in utero problems have been neglected.
India does not have a functional western model to follow in healthcare. The non-price rationing by queuing in Canada/ Britain and the price-based rationing in the US are not functioning effectively. India has its own system with private healthcare practitioners, who are largely unregulated, playing a significant role in meeting the healthcare needs of people.
More disclosure on the part of the private clinics and hospitals must be made mandatory so that the public can assess the quality of medical care and get some understanding of the track record of practitioners and hospitals.
Research has shown substantial medical expenditure occurs during the last two years of a person's life. A broad based hospitalisation catastrophic insurance must be offered to protect individuals in their old age.The benefits clearly defined and properly enforced can minimise fraud and delays in these programmes. Last but not the least, more collaboration is needed between doctors and economists to jointly pursue research and make health economics a robust discipline for specialisation.
Any other Ideas lemme know- Shout at drruchibhatt@yahoo.co.in

Comments

Popular posts from this blog

Artificial Intelligence Policy and Governance in HEALTHCARE

  Artificial Intelligence has become the new frontier for digital transformation. Several  #digitalhealth  businesses of today rely on Machine Learning,  #AI  and other such technologies to make healthcare delivery more efficient and comprehensive. However, the efficient and responsible use of AI tools is an ongoing discussion and would mean culture, data management, technology shifts in the industry, and required up-grading and training professionals for better coordination. Hence, with the growing market potential and interest in AI, it is imperative to develop a thoughtthrough regulatory and legal framework on the adoption and use of AI. I have set forward a hypotheses to design a policy framework for AI technologies in my paper- "𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐏𝐨𝐥𝐢𝐜𝐲 – 𝐀 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞" last year https://lnkd.in/emi3XWwa cited further by "𝐓𝐡𝐞 𝐐𝐮𝐚𝐧𝐝𝐚𝐫𝐲 𝐢𝐧 𝐃𝐚𝐭𝐚 𝐏𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐑

Artificial intelligence and Technology for Dentistry

Have you heard of this company  ORCA Dental AI ? ORCA combines clinical expertise with machine learning and AI technologies to create diagnostic reports, treatment plan suggestions and smart clinical predictions. Good to learn about these innovations that benefit every stakeholder in the value chain. Recently,  VideaHealth  raised $20M to Expand AI-Based Diagnostics led by Spark Capital including existing investors Zetta Venture Partners. Among its many benefits to dentists and patients are: – A 31% increase in diagnosis rate for cavities and 26% increase in treatment plan value; – An increase in case acceptance by patients due to second opinions; – Automated workflows accelerate treatment planning and charting; Another company touting AI-powered dental care and practice management is  Overjet , which announced a $42.5 million Series B funding round in December months after it had scored $27 million in Series A funding.  Pearl  provides AI for dental images to assist in diagnosis. It l

Big Data Analytics- The Microscope and Telescope for Pharma/CRO

This article is produced in consultation with Industry experts, and KOLs in India and across the world and especially highlights how “Predictive Analytics algorithms” are poised to provide Useful Analytics to the Pharma industry.   In today’s highly competitive market, it is extremely important for contract research and manufacturers to have access to information that allows them to target the specific segments of the pharmaceutical and biotechnology industry that are looking to outsource the particular services they provide.  Understanding shifts in annual outsourcing budgets and spending can help CROs and CMOs to better position themselves for capturing business, particularly at a time when many – if not all – pharma and biotech companies are looking to cut costs and streamline operations.  As per a recent report by NiceInsights, Analytical Services, Clinical Research, and Clinical Monitoring will be the most demanded services over the next 12 to 18 months. For CROs and CMOs looki